Back

Drug-coated balloons angioplasty versus drug-eluting stents for coronary artery bypass graft

31 August 2026 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Percutaneous coronary intervention and adjunctive therapeutic strategies Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tadao Aikawa

Juntendo University Graduate School of Medicine, Tokyo (Japan)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on percutaneous coronary intervention and adjunctive therapeutic strategies
Doctor G. Stone (New York City, US)
Presentation thumbnail
Temporal trends and outcomes of superelderly patients undergoing coronary intervention with and without acute myocardial infarction: Insights from the Japanese nationwide registry
Mr Y. Saito (Chiba, JP)
Abstract
Presentation thumbnail
One- versus three-month dual antiplatelet therapy in high-bleeding-risk patients undergoing PCI: a bayesian and trial sequential meta-analysis
Doctor K. Mahajan (Mandi, IN)
Abstract
Presentation thumbnail
Dual impairment of thrombotic and fibrinolytic pathways assessed by the global thrombosis test predicts adverse clinical outcomes after percutaneous coronary intervention
Professor J. Suh (Seongnam, KR)
Abstract

Access the full session

Session thumbnail
Percutaneous coronary intervention and adjunctive therapeutic strategies

The Event

Event poster

ESC Congress 2026

31 August 2026 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Drug-coated balloon versus drug-eluting stent following orbital atherectomy for calcified coronary artery: one-year outcomes of a retrospective cohort study
27 August 2021
thumbnail
Congress Presentation
Outcomes after percutaneous coronary intervention (PCI) in patients with prior coronary artery bypass grafting (cabg)
27 August 2021
thumbnail
Congress Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
1 September 2020
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources